Bavarian Nordic CEO notes progress in vaccine funding talks with Danish government

Monday, Bavarian Nordic presented promising data for the company's Covid-19 vaccine candidate. Danish state aid could play a role in helping the vaccine reach the public, and the firm's CEO says the talks are going well.

Bavarian Nordic CEO Paul Chaplin. | Photo: Bavarian Nordic / PR

The prospect of a Danish vaccine against Covid-19 is now one step closer to reality on Monday, when pharmaceutical company Bavarian Nordic presented a bundle of promising data. At the same time, the firm's talks with the Danish government concerning state financial support for the vaccine are progressing well, says Bavarian Nordic Chief Executive Paul Chaplien, reports Danish business daily Børsen.

"Yes, it's taking some time, but I will say the negotiations are going well, they are constructive and are moving forward. We remain confident in achieving financing. We're speaking with the Danish government, but we are also in communication with others. Strong data only helps [the possibility of receiving state funding, -ed.]," Chaplin tells the media.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs